Dr. Michael Dean Fabrizio, MD

Dr. Fabrizio practices at Medstar Medical Group II in Arlington, Virginia.

Dr. Fabrizio's NPI, 1427036664, was assigned on January 6, 2006. Dr. Fabrizio graduated from VCU School of Medicine in 1992. Dr. Fabrizio holds Virginia license 0101059177.

Dr. Fabrizio's primary practice is Medstar Medical Group II, at 2000 15th N St, Arlington, VA 22201 in Arlington County. The practice phone is (443) 444-5606.

Dr. Fabrizio's primary practice is Medstar Medical Group II in Arlington, Virginia. Dr. Fabrizio is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Fabrizio to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fabrizio practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Fabrizio's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Fabrizio is board certified in urology by the American Board of Urology. Dmand AI has Dr. Fabrizio's licenses on file in 5 states: Virginia, District of Columbia, Maryland, North Carolina and Pennsylvania.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, kidney stone disease, prostate cancer, prostate surgery and urinary endoscopy among the conditions Dr. Fabrizio treats.

CMS data shows 416 Medicare services from Dr. Fabrizio across 8 procedure codes in 2024, for 102 Medicare patients. Medicare paid $14,753 for them. Every service was in an office.

CMS counts 102 Medicare patients who saw Dr. Fabrizio in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fabrizio's median patient age at 63, with 20% women.

In 2024, Dr. Fabrizio wrote 284 Medicare Part D claims for 93 patients. 69% of them were for generic drugs. CMS names the drug for 233 of them, across 6 drugs with 11 or more claims each, at $1,036,306 in total drug cost. In 2023, CMS named 524 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Fabrizio for performance year 2024, reported as part of a group. Dr. Fabrizio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fabrizio as offering telehealth.

Dmand AI links 51 papers to Dr. Fabrizio, published from 2007 to 2021. 2020 was the busiest year, with 4. The most frequent topics are Laparoscopy, Prostatic Neoplasms and Prostatectomy. Dr. Fabrizio has published most often in J Endourol. Dr. Fabrizio's most frequent co-authors are John W. Davis, MD, James D. Brooks, MD and Peter R. Carroll, MD.

CMS Open Payments shows 1,943 general payments to Dr. Fabrizio from 61 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Astellas Pharma US Inc paid the most, $533,683.

Dmand AI lists 7 awards for Dr. Fabrizio, most recently Regional Top Doctor in 2014.

Dr. Fabrizio graduated from VCU School of Medicine in 1992. Dr. Fabrizio is a member of SLS.

Dr. Fabrizio is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.